![Michael J. Taylor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael J. Taylor
Nessuna posizione attualmente
Profilo
Michael J.
Taylor worked as a Senior Director of Clinical Development Sciences at Protein Design Labs, Inc. from 2005 to 2006.
He was also a Vice President of Non-Clinical Research at DURECT Corp.
in 2005.
From 2006 to 2009, he worked as a Vice President of Preclinical Development at Alexza Pharmaceuticals, Inc. He also held the position of Vice President of Preclinical Drug Safety at Limerick BioPharma, Inc. Dr. Taylor received a graduate and doctorate degree from Utah State University.
Precedenti posizioni note di Michael J. Taylor
| Società | Posizione | Fine |
|---|---|---|
| ALEXZA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2009 |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Corporate Officer/Principal | 01/08/2006 |
| DURECT | Corporate Officer/Principal | 01/01/2005 |
Limerick BioPharma, Inc.
 Limerick BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | - |
Formazione di Michael J. Taylor
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
39
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
DURECT Corp.
 DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
Utah State University
 Utah State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Limerick BioPharma, Inc.
Limerick BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
